RxDoctor Payments Data

Holly Overmiller, DO

Family Medicine · Caldwell, OHNPI 1407217995

Payments from drug & device makers

$778in general payments, 2019–2025

Across 50 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$207
  • AbbVie$92
  • Novo Nordisk$84
  • Amgen$71
  • Merck$59
  • Lilly USA, LLC$56
  • plus $210 from 9 others

What the payments were for

  • Food & beverage$778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$778 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$776
Medicare patients
47
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol90$91,081
EliquisApixaban87$72,133
JardianceEmpagliflozin75$62,357
TrulicityDulaglutide43$61,873
JanuviaSitagliptin Phosphate44$47,518
OzempicSemaglutide35$40,942
MounjaroTirzepatide22$27,188
XareltoRivaroxaban24$24,008
TradjentaLinagliptin21$21,736
RybelsusSemaglutide14$18,234
Bydureon BciseExenatide Microspheres22$17,163
Tresiba Flextouch U-200Insulin Degludec16$16,406
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,152
SymbicortBudesonide/Formoterol Fumarate32$8,826
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$207$111,059141 claims
Lilly USA, LLCTrulicity, Mounjaro$56$89,06165 claims
PfizerEliquis$17$72,13387 claims
Novo NordiskOzempic, Rybelsus$84$59,17649 claims
MerckJanuvia$59$47,51844 claims
Johnson & JohnsonXarelto$12$24,00824 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$24$20,29742 claims
AbbVieSavella, Synthroid$92$7,23957 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Caldwell

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →